A post hoc Tukey HSD test revealed significantly higher levels of CSF TMEM119 in the AD group compared to the control (p = 0.008), CM (p = 0.008), and FTLD (p = 0.013) groups (Table S3). This evidence concerns the gene TMEM119 and Alzheimer disease.